Takeda Begins Joint Research With Tri-TDI In US
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals, Memorial Sloan-Kettering Cancer Center in New York, Rockefeller University, and Weill Cornell University have agreed to begin joint research by establishing the non-profit Tri-Institutional Therapeutics Discovery Institute in January 2014.